Butterfly Network, Inc. Class A Common Stock (BFLY)
1.5700
-0.0400 (-2.48%)
NYSE · Last Trade: Sep 2nd, 10:21 AM EDT
Detailed Quote
Previous Close
1.610
Open
1.550
Bid
1.560
Ask
1.570
Day's Range
1.525 - 1.600
52 Week Range
1.150 - 4.980
Volume
744,360
Market Cap
45.43M
PE Ratio (TTM)
-1.805
EPS (TTM)
-0.9
Dividend & Yield
N/A (N/A)
1 Month Average Volume
3,427,322
Chart
About Butterfly Network, Inc. Class A Common Stock (BFLY)
Butterfly Network Inc is a digital health company that specializes in transforming the field of medical imaging through its innovative ultrasound technology. Utilizing a unique handheld, pocket-sized ultrasound device, the company aims to make ultrasound accessible and affordable, allowing healthcare professionals to perform imaging anytime and anywhere. By incorporating artificial intelligence into its platform, Butterfly Network enhances the capabilities of its devices, offering real-time diagnostics and improved decision-making for clinicians. The company is dedicated to improving patient outcomes by democratizing healthcare access and streamlining the imaging process in various medical settings. Read More
Clipper Distributing LLC (“Clipper”), a leading distributor partner and service provider in the veterinary health market, and Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, announced an agreement to commercialize Butterfly’s award-winning point-of-care ultrasound devices.
Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced its role in the international research study CAD LUS4TB that will evaluate the impact of AI-assisted point-of-care ultrasound (POCUS) on tuberculosis (TB) triage in under-resourced settings.
Butterfly Network, Inc. (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced its role in new research demonstrating the potential for machine learning (ML) models to support early detection of aortic stenosis (AS) using handheld ultrasound devices. The study, conducted by Tufts Medical Center and published in European Heart Journal – Imaging Methods and Practice, demonstrates that a ML model fine-tuned for use on Butterfly iQ+ devices can achieve high accuracy in identifying AS. The findings support the value of ML model development, and ultimately, are a positive step toward portable screening for earlier detection of this life-threatening condition.
First bullet in "Guidance" section should read: Revenue of $91 million to $95 million or approximately 13% growth (instead of "Revenue of $92 million to $96 million or approximately 15% growth").
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report second quarter 2025 financial results on August 1, 2025 before the market opens.
Butterfly Network, Inc. (“Butterfly”, “the Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound, today announced that the European Commission has officially initiated the review and stakeholder consultation period for the Company’s request to revoke Annex IV n. 14 of the European Commission’s Restriction of Hazardous Substances (RoHS) Directive – a temporary exemption historically granted for lead in single crystal piezoelectric materials for ultrasonic transducers.
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer and Chairman will present and host one-on-one investor meetings at William Blair 45th Annual Growth Stock Conference. The presentation will take place on Thursday, June 5, 2025, at 8:00 am CT in Chicago, IL.
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the first quarter ended March 31, 2025, and provided a business update.
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report first quarter 2025 financial results on May 2, 2025 before the market opens.
Butterfly Network, Inc. (“Butterfly” or the “Company”) (NYSE: BFLY), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, shared that its Butterfly iQ3 ultrasound device was featured in Episodes 12 and 13 of the popular HBO Max medical drama The Pitt. The show has gained a significant following, including among healthcare professionals, given its realistic and compelling depiction of modern medical practices.
Butterfly Network exceeded Q4 estimates with 35% revenue growth. William Blair sees strong upside, citing homecare potential and a growing ultrasound market.
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate at the Virtual Oppenheimer 35th Annual Healthcare MedTech & Services Conference on March 18, 2025. Joseph DeVivo, President, Chief Executive Officer & Chairman and Heather Getz, Executive Vice President & Chief Financial and Operations Officer will host one-on-one investor meetings and take part in a Fireside Chat at 11:20am EDT.
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the fourth quarter and year ended December 31, 2024, and provided a business update.
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”) a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will present and host one-on-one investor meetings at the TD Cowen 45th Annual Health Care Conference in Boston on March 3, 2025. Heather Getz, Executive Vice President & Chief Financial and Operations Officer will host one-on-one meetings and will present a business overview at 1:10pm EST.
Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, announced that it will report fourth quarter and full year 2024 financial results on Friday, February 28, 2025, at 8:00 am ET.
